42.68 0.00 (0.00%)
After hours: 4:00PM EDT
|Bid||37.93 x 800|
|Ask||42.85 x 800|
|Day's Range||42.61 - 44.67|
|52 Week Range||38.06 - 82.35|
|Beta (3Y Monthly)||1.65|
|PE Ratio (TTM)||255.57|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
How far off is Surmodics, Inc. (NASDAQ:SRDX) from its intrinsic value? Using the most recent financial data, we'll...
With the conclusion of BioScrip (BIOS)-Option Care consolidation, the newly formed company gets its new name Option Care Health, Inc. under the ticker symbol BIOS.
SurModics (SRDX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Surmodics (SRDX) continues to gain from core Medical Devices unit, which saw significant contribution from the SurVeil deal with Abbott in Q3.
If you're interested in Surmodics, Inc. (NASDAQ:SRDX), then you might want to consider its beta (a measure of share...
Hedge funds are known to underperform the bull markets but that's not because they are terrible at stock picking. Hedge funds underperform because their net exposure in only 40-70% and they charge exorbitant fees. No one knows what the future holds and how market participants will react to the bountiful news that floods in each […]
Zacks.com featured highlights include: LexinFintech, Veeco, Helen of Troy, Surmodics and Herman Miller
Zacks.com featured highlights include: LexinFintech, Herman Miller, Interactive Brokers, ConnectOne and Surmodics
Hedge funds run by legendary names like George Soros and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to have a minimum of $1 million liquid to invest in a hedge fund) by spending enormous resources on analyzing and uncovering data about small-cap stocks that the […]
Surmodics (SRDX) consistently gains traction from its core Medical Devices unit, which witnesses a substantial contribution from the SurVeil pact with Abbott.
On a per-share basis, the Eden Prairie, Minnesota-based company said it had net income of 9 cents. Earnings, adjusted for non-recurring gains, were 7 cents per share. The drug delivery technology company ...